Xylem Inc.XYLEarnings & Financial Report
Xylem is one of the two types of transport tissue in vascular plants, the other being phloem; both of these are part of the vascular bundle. The basic function of the xylem is to transport water upward from the roots to parts of the plants such as stems and leaves, but it also transports nutrients. The word xylem is derived from the Ancient Greek word ξύλον (xúlon), meaning "wood"; the best-known xylem tissue is wood, though it is found throughout a plant.
XYL Q4 2025 Key Financial Metrics
Revenue
$2.4B
Gross Profit
$932.0M
Operating Profit
$353.0M
Net Profit
$335.0M
Gross Margin
38.9%
Operating Margin
14.7%
Net Margin
14.0%
YoY Growth
6.3%
EPS
$1.37
Financial Flow
Xylem Inc. Q4 2025 Financial Summary
Xylem Inc. reported revenue of $2.4B (up 6.3% YoY) for Q4 2025, with a net profit of $335.0M (up 2.8% YoY) (14.0% margin). Cost of goods sold was $1.5B, operating expenses totaled $579.0M.
Key Financial Metrics
| Total Revenue | $2.4B |
|---|---|
| Net Profit | $335.0M |
| Gross Margin | 38.9% |
| Operating Margin | 14.7% |
| Report Period | Q4 2025 |
Revenue Breakdown
Xylem Inc. Q4 2025 revenue of $2.4B breaks down across 2 segments, led by Products at $2.0B (82.8% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Products | $2.0B | 82.8% |
| Services | $412.0M | 17.2% |
Xylem Inc. Revenue by Segment — Quarterly Trend
Xylem Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Products and Services) has evolved quarter over quarter.
| Segment | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Products | $2.0B | — | — | — |
| Services | $412.0M | — | — | $360.0M |
Xylem Inc. Annual Revenue by Year
Xylem Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $9.0B). Click any linked year to see what changed vs the prior annual report.
Xylem Inc. Quarterly Revenue & Net Profit History
Xylem Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $2.4B | +6.3% | $335.0M | 14.0% |
| Q3 2025 | $2.3B | +7.8% | $227.0M | 10.0% |
| Q2 2025 | $2.3B | +6.1% | $226.0M | 9.8% |
| Q1 2025 | $2.1B | +1.8% | $169.0M | 8.2% |
| Q4 2024 | $2.3B | +6.5% | $326.0M | 14.5% |
| Q3 2024 | $2.1B | +1.3% | $217.0M | 10.3% |
| Q2 2024 | $2.2B | +26.0% | $194.0M | 8.9% |
| Q1 2024 | $2.0B | +40.4% | $153.0M | 7.5% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.03B | $2.17B | $2.10B | $2.26B | $2.07B | $2.30B | $2.27B | $2.40B |
| YoY Growth | 40.4% | 26.0% | 1.3% | 6.5% | 1.8% | 6.1% | 7.8% | 6.3% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $15.92B | $15.77B | $16.05B | $16.49B | $16.56B | $17.19B | $17.30B | $17.63B |
| Liabilities | $5.72B | $5.42B | $5.45B | $5.61B | $5.50B | $5.88B | $5.85B | $5.88B |
| Equity | $10.20B | $10.34B | $10.59B | $10.64B | $10.82B | $11.07B | $11.21B | $11.48B |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $89.0M | $288.0M | $311.0M | $575.0M | $33.0M | $305.0M | $360.0M | $543.0M |